A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₺8.313,75, with a 24-hour trading volume of ₺19,28B. The asset's market cap is ₺12,89T, after moving 0.59% in the last day.
Tokenized AstraZeneca PLC is trading at ₺4.649,54, with a tokenized market cap of ₺2,63B and a 24-hour trading volume of ₺34,16M. The tokenized asset has moved 4.72% in the past 24 hours.